We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
2376
Integra LifeSciences
IART
$1.52B
$5.02K ﹤0.01%
404
+258
+177% +$3.43K
ONT
2377
Onterris Inc
ONT
$718M
$4.99K ﹤0.01%
201
+184
+1,082% +$4.86K
ENR icon
2378
Energizer
ENR
$1.44B
$4.97K ﹤0.01%
250
-2,250
-90% -$49K
DCTH icon
2379
Delcath Systems
DCTH
$412M
$4.96K ﹤0.01%
491
-14
-3% -$139
SEZL
2380
Sezzle
SEZL
$5.27B
$4.95K ﹤0.01%
78
TWST icon
2381
Twist Bioscience
TWST
$5.39B
$4.95K ﹤0.01%
156
ISTB icon
2382
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
$4.88K ﹤0.01%
100
CIVB icon
2383
Civista Bancshares
CIVB
$595M
$4.84K ﹤0.01%
218
+124
+132% +$2.74K
SAFE
2384
Safehold
SAFE
$1.19B
$4.79K ﹤0.01%
350
-698
-67% -$9.92K
PACB icon
2385
Pacific Biosciences
PACB
$422M
$4.78K ﹤0.01%
2,554
+1,189
+87% +$2.29K
TTGT icon
2386
TechTarget
TTGT
$275M
$4.77K ﹤0.01%
+883
New +$4.75K
HLIO icon
2387
Helios Technologies
HLIO
$2.59B
$4.71K ﹤0.01%
88
+42
+91% +$2.26K
CWCO icon
2388
Consolidated Water Co
CWCO
$472M
$4.66K ﹤0.01%
132
PFF icon
2389
iShares Preferred and Income Securities ETF
PFF
$13.2B
$4.64K ﹤0.01%
150
ACCO icon
2390
Acco Brands
ACCO
$381M
$4.61K ﹤0.01%
1,235
+160
+15% +$594
ECVT icon
2391
Ecovyst
ECVT
$1.34B
$4.6K ﹤0.01%
473
CBU icon
2392
Community Bank
CBU
$3.5B
$4.6K ﹤0.01%
80
CBZ icon
2393
CBIZ
CBZ
$2.39B
$4.59K ﹤0.01%
91
-81
-47% -$4.26K
BWIN
2394
Baldwin Insurance Group
BWIN
$2.67B
$4.59K ﹤0.01%
191
+42
+28% +$1.07K
LTBR icon
2395
Lightbridge
LTBR
$263M
$4.59K ﹤0.01%
363
AG icon
2396
First Majestic Silver
AG
$8.01B
$4.58K ﹤0.01%
275
-514
-65% -$7.14K
PSEC icon
2397
Prospect Capital
PSEC
$1.12B
$4.56K ﹤0.01%
1,762
+1,451
+467% +$3.88K
HEI.A icon
2398
HEICO Corp Class A
HEI.A
$36.3B
$4.54K ﹤0.01%
18
ELVN icon
2399
Enliven Therapeutics
ELVN
$3.77B
$4.54K ﹤0.01%
295
OLPX
2400
DELISTED
Olaplex Holdings
OLPX
$4.54K ﹤0.01%
3,387
-256
-7% -$305

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.